- Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide- or tumor lysatepulsed dendritic cells. Nat Med 1998: 4: 328-32.
- Nestle FO, Dendritic cell vaccination for cancer therapy. Oncogene 2000: 19: 6673-9.
- Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature 2001; 411: 380-4.
- Coulie PG, Brichard V, Van Pel A. et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994: 180: 35-42.
- Van den Eynde B, Peeters O, De Backer O, Gaugler B, Lucas S. Boon T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 1995: 182: 689-98.
- Wölfel T, Hauer M, Schneider J, et al. A p161NK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 1995; 269: 1281-4.
- Boon T. van der Bruggen P. Human tumor antigens recognized by T lymphocytes. J Exp Med 1996; 183: 725-829.
- Robbins PF, EI-Gamil M. Li YF, et al. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J Exp Med 1996: 183: 1185-92.
- Chen YT, Scanlan MJ, Sahin U, et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 1997: 94: 1914-8.
- Gnjatic S, Cai Z, Viguier M, Chouaib S, G u il let JG, Choppin J. Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas. J Imniunol 1998; 160: 328-33.
- Scanlan MJ, Chen Y-T, Williamson B, et al. Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 1998; 76: 652-8.
- Scanlan MJ, Williamson B, Jungbluth A, et al. Isoforms of the human PDZ-73 protein exhibit differential tissue expression. Biochim Biophys Acta 1999; 1445: 39-52.
- Zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000: 92: 690-8.
- Gaugler B, Brouwenstijn N, Vantomme V. et al. A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma. Immunogenetics 1996: 44: 323-30.
- Eichmüller S, Usener D, Jochim A, Schadendorf D. mRNA expression of tumor-associated antigens in melanoma tissues and cell lines. Exp Dermatol 2001 : In press.
- De Backer O. Arden KC, Boretti M, et al. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. Cancer Res 1999: 59: 3157-65.
- Miyata Y, Akashi M, Nishida E. Molecular cloning and characterization of a novel member of the MAP kinase superfamily. Genes Cells 1999: 4: 299-309.
- Flad T, Spengler B. Kalbacher H, et al. Direct identification of major histocompatibility complex class Ibound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method. Cancer Res 1998: 58: 5803-11.
- Russo V, Dalerba P, Ricci A, et al. MAGE BAGE and GAGE genes expression in fresh epithelial ovarian carcinomas [letter]. Int J Cancer 1996: 67: 457-60.
- Brinkniann U, Vasniatzis G, Lee B, Yerushalnii N, Essand M, Pastan I. PAGE-1, an X chromosomelinked GAGE-like gene that is expressed in normal and neoplastic prostate, testis. and uterus. Proc Natl Acad Sci USA 1998; 95: 10757-62.
- Chen ME, Lin SH, Chung LW, Sikes RA. Isolation and characterization of PAGE-1 and GAGE-7. New genes expressed in the LNCaP prostate cancer progression model that share homology with melanoma-associated antigens. J Biol Chem 1998: 273: 17618-25.
- Gillespie AM, Rodgers S, Wilson AP, et al. MAGE. BAGE and GAGE: tumour antigen expression in benign and malignant ovarian tumors ovarian tissue. Br J Cancer 1998; 78: 816-21.
- Neumann E, Engelsberg A, Decker J, et al. Heterogeneous expression of the tumor-associated antigens RAGE-1. PRAME. and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies? Cancer Res 1998: 58: 4090-5.
- Scarcella DL, Chow CW, Gonzales MF, Economou C, Brasseur F, Ashley DM. Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers. Clin Cancer Res 1999: 5: 335-41.
- Van den Eynde BJ, Boon T. Tumor antigens recognized by T lymphocytes. Int J Clin Lab Res 1997: 27: 81-6.
Tumor-associated Antigens as Possible Targets for Immune Therapy in Head and Neck Cancer: Comparative mRNA Expression Analysis of RAGE and GAGE Genes
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.